Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta-analysis.

McLaughlin J, Scotton WJ, Ryan NS, Hardy JA, Shoai M

Open source

DOI
10.1002/alz.14314
Published
2024 Dec
Container
Alzheimer's & dementia : the journal of the Alzheimer's Association
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/alz.14314,
  title = {Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta-analysis.},
  author = {McLaughlin J and Scotton WJ and Ryan NS and Hardy JA and Shoai M},
  year = {2024},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  doi = {10.1002/alz.14314},
  url = {https://doi.org/10.1002/alz.14314}
}

RIS

TY  - JOUR
TI  - Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta-analysis.
AU  - McLaughlin J
AU  - Scotton WJ
AU  - Ryan NS
AU  - Hardy JA
AU  - Shoai M
PY  - 2024
JO  - Alzheimer's & dementia : the journal of the Alzheimer's Association
DO  - 10.1002/alz.14314
UR  - https://doi.org/10.1002/alz.14314
ER  - 

APA

J, M., WJ, S., NS, R., JA, H., & M, S. (2024). Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta-analysis.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.14314

Source records